Fox Run Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,366
Closed -$137K 912
2024
Q4
$137K Buy
35,366
+17,971
+103% +$99.2K 0.02% 789
2024
Q3
$128K Buy
+17,395
New +$114K 0.03% 723
2023
Q3
Sell
-11,395
Closed -$133K 708
2023
Q2
$133K Buy
+11,395
New +$108K 0.04% 620
2018
Q2
Sell
-10,478
Closed -$304K 664
2018
Q1
$304K Buy
+10,478
New +$305K 0.07% 487
2016
Q3
Sell
-35,600
Closed -$422K 490
2016
Q2
$422K Buy
+35,600
New +$443K 0.2% 172

Other funds holding BAK

Fox Run Management's BAK Position: Q1 2025 in Review

Fox Run Management sold out of Braskem (BAK) in Q1 2025, closing a stake of 35,366 shares — an estimated $137K sold.

Fox Run Management first reported a position in BAK in Q2 2016 and held it in 5 quarters. The position peaked at $422K in Q2 2016. 58 funds tracked by Wall St. Rank hold BAK as of Q1 2025.

  • Fox Run Management reported no remaining Braskem position as of Q1 2025 after selling out during the quarter.
  • Fox Run Management sold 35,366 Braskem shares in Q1 2025, an estimated $137K.
  • Fox Run Management first reported a position in Braskem in Q2 2016 and held it in 5 quarters.
  • Fox Run Management's Braskem position peaked at $422K in Q2 2016.
  • 58 funds tracked by Wall St. Rank held Braskem as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.